Plasma concentrations of cholesteryl ester transfer protein in hyperlipoproteinemia. Relation to cholesteryl ester transfer protein activity and other lipoprotein variables.
- 1 July 1991
- journal article
- abstracts
- Published by Wolters Kluwer Health in Arteriosclerosis and Thrombosis: A Journal of Vascular Biology
- Vol. 11 (4) , 797-804
- https://doi.org/10.1161/01.atv.11.4.797
Abstract
Cholesteryl ester transfer protein (CETP) mediates an important pathway for reverse cholesterol transport. Concentrations of CETP in fasting plasma were measured by radioimmunoassay in two different groups of hyperlipoproteinemic subjects. Plasma CETP concentrations measured by radioimmunoassay correlated closely with cholesterol ester transfer activity in normal plasma (r = 0.86). In the first group of 58 patients, plasma CETP concentrations were significantly increased, as compared with those in 79 normal subjects and in hypercholesterolemic (+26%) and combined hyperlipoproteinemic (+25%) subjects but were not altered in moderately hypertriglyceridemic subjects. Marked elevations in plasma CETP levels were documented in patients with dysbetalipoproteinemia (+68%) and severe chylomicronemia (+85%). Similar results were obtained in a second population of 50 hyperlipoproteinemic subjects. Significant correlations were found between plasma CETP levels and total cholesterol (r = 0.52), very low density lipoprotein (VLDL) cholesterol (r = 0.63), and apolipoprotein E concentration (r = 0.40). Correction of the lipoprotein phenotype by dietary means resulted in significant reductions in plasma CETP concentrations in patients with chylomicronemia and dysbetalipoproteinemia. In these subjects, plasma high density lipoprotein cholesterol concentrations increased as CETP decreased. These studies indicate that CETP levels increase in association with enhanced peripheral cholesterol transport via low density lipoprotein, beta-VLDL, or chylomicron remnants.Keywords
This publication has 16 references indexed in Scilit:
- Increase in plasma cholesteryl ester transfer protein during probucol treatment. Relation to changes in high density lipoprotein composition.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency.Journal of Clinical Investigation, 1990
- Atherogenic diet increases cholesteryl ester transfer protein messenger RNA levels in rabbit liver.Journal of Clinical Investigation, 1990
- Distribution and concentration of cholesteryl ester transfer protein in plasma of normolipemic subjects.Journal of Clinical Investigation, 1990
- Accelerated transfer of cholesteryl esters in dyslipidemic plasma. Role of cholesteryl ester transfer protein.Journal of Clinical Investigation, 1987
- Apolipoprotein E is the determinant that mediates the receptor uptake of beta-very low density lipoproteins by mouse macrophages.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1986
- Characterization of monoclonal antibodies against human low density lipoprotein.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1983
- Characterization of monoclonal antibodies against human apolipoprotein E.Journal of Clinical Investigation, 1981
- Cholesterol ester exchange between human plasma high and low density lipoproteins mediated by a plasma protein factorAtherosclerosis, 1978
- Stimulation of cholesterol ester exchange by lipo-protein-free rabbit plasmaBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1975